McKesson (MCK)
(Delayed Data from NYSE)
$537.21 USD
+1.12 (0.21%)
Updated Apr 30, 2024 04:00 PM ET
After-Market: $537.21 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value D Growth B Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$537.21 USD
+1.12 (0.21%)
Updated Apr 30, 2024 04:00 PM ET
After-Market: $537.21 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value D Growth B Momentum B VGM
Zacks News
McKesson (MCK) to Pay $150 Million to Department of Justice
by Zacks Equity Research
McKesson (MCK) has finalized to resolve U.S. Drug Enforcement Administration and Department of Justice potential federal civil and administrative claims.
McKesson (MCK) Closes Rexall Health Acquisition in Canada
by Zacks Equity Research
McKesson Corporation (MCK) announced that it has completed the acquisition of Canada-based Rexall Health for $2.1 billion
A Whole Lot of Nothing
by Sheraz Mian
Stocks haven't done much lately and the trend will likely continue for some time.
Top Research Reports for Morgan Stanely, Union Pacific & AbbVie
by Sheraz Mian
Today's must-read reports are for AbbVie (ABBV), Morgan Stanley (MS) and Union Pacific (UNP).
Where Do We Go From Here?
by Sheraz Mian
The post-Brexit rally has taken many by surprise, but it does beg the question of where we go from here.
Top 6 Research Reports for July 7, 2016
by Sheraz Mian
Today's must-read reports are for Expedia (EXPE), BP (BP) and McKesson (MCK).
Top 6 Research Reports for June 30, 2016
by Sheraz Mian
Today's must-read reports are for Alphabet (GOOGL), Monsanto (MON) and McKesson (MCK).
Top 3 MedTech Stocks Poised to Gain this Earnings Season
by Zacks Equity Research
A bipartisan group of ten senators signed on a bill to repeal the 2.3% federal excise tax on medical device makers.